Literature DB >> 20651693

Elevation in plasma creatinine and renal failure in premature neonates without major anomalies: terminology, occurrence and factors associated with increased risk.

M W Walker1, R H Clark, A R Spitzer.   

Abstract

OBJECTIVE: The goal of this study was to describe the changes in plasma creatinine levels that occur in prematurely born neonates, to better understand the use of the terms 'renal dysfunction' and 'renal failure' among premature neonates, as well as to evaluate the demographic and outcome characteristics associated with renal problems in preterm neonates who have no major congenital anomalies. STUDY
DESIGN: Retrospective review of the Pediatrix neonatal intensive care patient clinical data warehouse. RESULT: The study cohort consisted of neonates born with an estimated gestational age of ≤ 30 completed weeks in whom there was no report of any major anomalies (n=66,526). In this group of 66,526 neonates, there were 64,030 (96.2%) with no report of renal dysfunction or failure, 1239 (1.9%) in whom there was a diagnosis of renal dysfunction and 1257 infants (1.9%) with a diagnosis of renal failure. The clinical circumstances most strongly associated with a diagnosis of renal dysfunction and/or renal failures were low gestational age and birth weight. In addition, multivariate analysis showed that the factors associated with an increased risk of renal problems were vasopressor use during the first 7 days after birth, grade 3 or 4 intraventricular hemorrhage, a patent ductus arteriosus, necrotizing enterocolitis, male gender, the use of indomethacin, a positive blood culture during the first 7 days after birth, the use of high-frequency ventilation in the first 2 days after birth, non-White race and prolonged exposure to antibiotics. Mortality was higher in patients with renal problems than in neonates without renal problems (39.1 vs 10.2%, P<0.01) and higher in neonates with renal failure than in neonates with renal dysfunction (57.6 vs 20.1%, P<0.01).
CONCLUSION: Renal dysfunction and/or failure are common diagnoses, especially in extremely premature neonates and there are potentially modifiable factors that increase the risk of renal problems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651693     DOI: 10.1038/jp.2010.82

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  30 in total

1.  Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. A pilot study.

Authors:  Kosmas Sarafidis; Eleni Tsepkentzi; Elisavet Diamanti; Eleni Agakidou; Anna Taparkou; Vasiliki Soubasi; Fotios Papachristou; Vasiliki Drossou
Journal:  Pediatr Nephrol       Date:  2014-02       Impact factor: 3.714

Review 2.  The interplay between drugs and the kidney in premature neonates.

Authors:  Michiel F Schreuder; Ruud R G Bueters; Karel Allegaert
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

Review 3.  Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

Authors:  Hanna E Reinebrant; Cynthia Pileggi-Castro; Carla L T Romero; Rafaela A N Dos Santos; Sailesh Kumar; João Paulo Souza; Vicki Flenady
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

Review 4.  The Pediatrix BabySteps® Data Warehouse--a unique national resource for improving outcomes for neonates.

Authors:  Alan R Spitzer; Dan Ellsbury; Reese H Clark
Journal:  Indian J Pediatr       Date:  2014-10-17       Impact factor: 1.967

5.  Impact of Kidney Disease on Survival in Neonatal Extracorporeal Life Support.

Authors:  Aaron Wightman; Miranda C Bradford; Jordan Symons; Thomas V Brogan
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

6.  Is urinary neutrophil gelatinase-associated lipocalin able to predict acute kidney injury episodes in very low birth weight infants in clinical settings?

Authors:  Elvira Parravicini; Chiara Locatelli; John M Lorenz; Sheri L Nemerofsky; David A Bateman
Journal:  Pediatr Res       Date:  2016-07-13       Impact factor: 3.756

7.  Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin.

Authors:  J E Constance; D Reith; R M Ward; A Balch; C Stockmann; E K Korgenski; E A Thorell; C M T Sherwin
Journal:  J Perinatol       Date:  2017-06-08       Impact factor: 2.521

Review 8.  Calcium channel blockers for inhibiting preterm labour and birth.

Authors:  Vicki Flenady; Aleena M Wojcieszek; Dimitri N M Papatsonis; Owen M Stock; Linda Murray; Luke A Jardine; Bruno Carbonne
Journal:  Cochrane Database Syst Rev       Date:  2014-06-05

9.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

Review 10.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.